West Pharmaceutical Services, Inc. (WST)
328.03
+4.44
(+1.37%)
USD |
NYSE |
Jun 18, 16:00
328.03
0.00 (0.00%)
After-Hours: 20:00
West Pharmaceutical Services SG&A Expense (Quarterly) : 99.50M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 99.50M |
| December 31, 2025 | 107.00M |
| September 30, 2025 | 102.70M |
| June 30, 2025 | 95.90M |
| March 31, 2025 | 88.00M |
| December 31, 2024 | 85.30M |
| September 30, 2024 | 83.50M |
| June 30, 2024 | 83.00M |
| March 31, 2024 | 86.70M |
| December 31, 2023 | 90.00M |
| September 30, 2023 | 89.00M |
| June 30, 2023 | 88.40M |
| March 31, 2023 | 86.00M |
| December 31, 2022 | 85.70M |
| September 30, 2022 | 66.30M |
| June 30, 2022 | 81.50M |
| March 31, 2022 | 83.40M |
| December 31, 2021 | 98.00M |
| September 30, 2021 | 91.90M |
| June 30, 2021 | 92.70M |
| March 31, 2021 | 80.20M |
| December 31, 2020 | 76.30M |
| September 30, 2020 | 76.20M |
| June 30, 2020 | 77.70M |
| March 31, 2020 | 71.80M |
| Date | Value |
|---|---|
| December 31, 2019 | 69.00M |
| September 30, 2019 | 64.80M |
| June 30, 2019 | 70.30M |
| March 31, 2019 | 68.60M |
| December 31, 2018 | 59.70M |
| September 30, 2018 | 64.90M |
| June 30, 2018 | 70.00M |
| March 31, 2018 | 68.30M |
| December 31, 2017 | 59.60M |
| September 30, 2017 | 62.60M |
| June 30, 2017 | 61.30M |
| March 31, 2017 | 62.50M |
| December 31, 2016 | 60.90M |
| September 30, 2016 | 58.30M |
| June 30, 2016 | 62.50M |
| March 31, 2016 | 58.10M |
| December 31, 2015 | 62.40M |
| September 30, 2015 | 54.60M |
| June 30, 2015 | 71.70M |
| March 31, 2015 | 55.20M |
| December 31, 2014 | 58.80M |
| September 30, 2014 | 56.00M |
| June 30, 2014 | 57.50M |
| March 31, 2014 | 56.40M |
| December 31, 2013 | 60.00M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Globus Medical, Inc. | 297.78M |
| Thermo Fisher Scientific, Inc. | 2.181B |
| Bio-Techne Corp. | 109.34M |
| Cardinal Health, Inc. | 1.542B |
| Eli Lilly & Co. | 2.934B |